Sort
326,823 grants matching “clinical trial”
Home Use of MD-Logic Automated Insulin Delivery System: Safety and Efficacy
$1,991,668Richard Mauritz Bergenstal · Healthpartners Institute · UC4 · FY2015 · DK
SEARCH: Cancer Screening Effectiveness and Research in Community-based Healthcare
$1,991,655Diana Sm Buist · Kaiser Foundation Health Plan Of Washington · UC2 · FY2010 · CA
SPORE in Lung Cancer
$1,991,619Eric B. Haura · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2012 · CA
COVID-19: Identification and Development of Clinical Candidates to Treat SARS-CoV-2
$1,991,523Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Development of an Integrated Canine Data Commons (ICDC)
$1,991,470John Otridge · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
Molecular Profiling of Clinical Specimens
$1,991,384Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity
$1,991,327James Alexander Thomson · Morgridge Institute For Research, Inc. · UH3 · FY2015 · TR
Study of Osteoporotic Fractures
$1,991,274Steven R Cummings · California Pacific Med Ctr Res Institute · R01 · FY2008 · AG
The Center for Predictive Computational Phenotyping-1 Overall
$1,991,007Mark W Craven · University Of Wisconsin-Madison · U54 · FY2014 · AI
Dietary Restriction, GH/IGF-1 & Mechanisms of Cellular Protection and Regeneration
$1,990,986Valter D. Longo · University Of Southern California · P01 · FY2021 · AG
LASER CELL PROCESSING FOR BASIC AND CLINICAL RESEARCH
$1,990,955Cyntellect, Inc. · R44 · FY2002 · RR
Molecular Strategies to Widen the Therapeutic Index of Radiotherapy
$1,990,934Quynh-Thu X Le · Stanford University · P01 · FY2025 · CA
NIDA Clinical Trials Network: New York Node
$1,990,902John P Rotrosen · New York University School Of Medicine · UG1 · FY2021 · DA
NK Cells, Their Receptors and Unrelated Donor Transplant
$1,990,871Jeffrey S Miller · University Of Minnesota · P01 · FY2008 · CA
Rational Systemic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA)
$1,990,835Arnab Kumar Chatterjee · Scripps Research Institute, The · N01 · FY2024 · AI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,990,761Thomas Waldmann · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,990,761Thomas A Waldmann · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
CENTER FOR AIDS RESEARCH(CFAR)
$1,990,746Michael Marcel Lederman · Case Western Reserve University · P30 · FY2006 · AI
Psychotherapy Development Research Center
$1,990,745Bruce James Rounsaville · Yale University · P50 · FY2006 · DA
Growth Factor Imaging
$1,990,651Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Immune tolerance network: kidney transplantation
$1,990,629Jeffrey Bluestone · · N01 · FY2013 · AI
PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology Study
$1,990,623Meredith Hay · University Of Arizona · U01 · FY2025 · AG
Androgen Receptor Action in Castration Resistant Prostate Cancer
$1,990,456Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2025 · CA
COBRE Center for Neuromodulation (CCN)
$1,990,455Benjamin D Greenberg · Butler Hospital (Providence, Ri) · P20 · FY2022 · GM
NCI Enterprise caCORE
$1,990,190Kenneth Buetow · Office Of The Director, Nci · ZIH · FY2009 · CA